Guide for Authors  by unknown
GUIDE FOR AUTHORS
Value in Health Regional Issues is a peer-reviewed publication of the 
 International Society for Pharmacoeconomics and Outcomes Research, 
focusing on Asia, Latin American, Central & Eastern Europe, Western Asia, 
and Africa. Its mission is to provide a forum for the advancement and dis-
semination of knowledge and research in pharmacoeconomics and the 
healthrelated outcomes of disease and treatment processes, and there-
fore solicits original contributions in health care policty analysis, outcomes 
research (clinical, economic, and patient-reported) empirical studies, 
methodological studies, and manuscripts on health care resources in the 
region. Health care decision-maker commentaries from health outcomes 
researchers and policy makers are welcome. Commentaries are expected 
to include discussion on how researchers can better respond to the needs 
of those making clinical and ﬁ nancial decisions in health care.
Value in Health Regional Issues does not consider papers reporting 
data series or data sets that do not include appropriate statistical conﬁ -
dence intervals and/or other measures of statistical imprecision. Value 
in Health Regional Issues also does not consider papers reporting mod-
eling results that do not include sensitivity analysis of key and inﬂ uential 
model parameters.
Authors for whom English is a second language that would like to 
submit a manuscript in English may choose to have their manuscript 
professionally edited before submisstion or during the review process. 
Authors wishing to employ a professional English-language editing 
service (English manuscript submissions only) should make contact 
and arrange payment with the editing service of their choice. For more 
details regarding the recommended services, see http://support. 
 elsevier.com/.
Value in Health Regional Issues articles may be published in a language 
of the region other than English (i.e. Chinese, Korean, Japanese, Thai, 
Indonesian, etc. for Asia; Spanish, Portuguese, etc. for Latin America; 
and Russian, Polish, Arabic, etc. for Central & Eastern Europe, Western 
Asia and African region). All manuscripts accepted for publication 
in Value in Health Regional Issues must have an abstract and 
keywords in English as well as the language of the manuscript (if 
not English). Languages for a speciﬁ c issue are decided by the Value in 
Health Regional Issues Editorial Board.
The criteria for a manuscript to be considered for Value in Health Regional 
 Issues are as follows:
•  First author must reside in the region to which a speciﬁ c regional 
issue is dedicated; and
• The empirical study manuscript submitted to Value in Health 
 Regional Issues must include subjects from population(s) in the 
 region to which a speciﬁ c regional issue is dedicated.
For further details concerning the types of articles and eligible regions 
suitable for Value in Health Regional Issues, see: http://www.ispor.org/ 
publications/VIHRI/VIHRImain.asp.
I. ETHICS IN PUBLISHING
For information on Ethics in Publishing and Ethical guidelines for journal
publication see http://www.elsevier.com/publishingethics and http:// 
www.elsevier.com/ethicalguidelines.
II. CONFLICT OF INTEREST
All authors must disclose any ﬁ nancial and personal relationships with 
other people or organisations that could inappropriately inﬂ uence (bias) 
their work. Examples of potential conﬂ icts of interest include employ-
ment, consultancies, stock ownership, honoraria, paid expert testimony, 
patent applications/registrations, and grants or other funding. See also 
http://www.elsevier.com/conﬂ ictsoﬁ nterest.
III. SUBMISSION DECLARATION
Submission of an article implies that the work described has not been 
published previously (except in the form of an abstract or as part of a 
published lecture or academic thesis), that it is not under consideration 
for publication elsewhere, that its publication is approved by all authors 
and tacitly or explicitly by the responsible authorities where the work 
was carried out, and that, if accepted, it will not be published elsewhere 
including electronically in the same form, in English or in any other lan-
guage, without the written consent of the copyright-holder.
IV. RETAINED AUTHOR RIGHTS
As an author you (or your employer or institution) retain certain rights; 
for details you are referred to: http://www.elsevier.com/authorsrights.
V. FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established agreements and developed policies to allow 
 authors whose articles appear in journals published by Elsevier, to comply 
with potential manuscript archiving requirements as speciﬁ ed as condi-
tions of their grant awards. To learn more about existing agreements and 
policies please visit http://www.elsevier.com/fundingbodies.
VI. MANUSCRIPT SUBMISSION AND  SPECIFICATIONS
Submissions received eight months prior to the publication date will be 
considered by the upcoming issue. Publication timeline for a speciﬁ c 
 regional issue is below:
•  Value in Health Regional Issues for Asia is published in May.
•  Value in Health Regional Issues for Central & Eastern Europe,  Western 
Asia and Africa is published in August.
• Value in Health Regional Issues for Latin America is published in 
 December.
To submit a manuscript to Value in Health Regional Issues, please 
go to: http://www.ispor.org/publications/VIHRI/submission_instruction.
asp. For assistance, authors may contact the Value in Health Regional 
Issues  editorial ofﬁ ce at: vihri@ispor.org.
If submissions are larger than 500 KB, they should be compressed 
using PKZIP or WINZIP.
Authors will be required to assign copyright of their papers. Copyright 
assignment is a condition of publication and papers will not be passed 
to the publisher for production unless copyright has been assigned. An 
appropriate copyright assignment form can be found at the following 
 address: http://www.ispor.org/publications/VIHRI/submission_instruc-
tion.asp. A faxed copy of this completed and signed form is acceptable; 
fax to 609-586-4982 or email to: vihri@ispor.org.
If excerpts from other copyrighted works are included, the author(s) 
must obtain written permission from the copyright owners and credit the 
source(s) in the article. Elsevier has preprinted forms for use by authors 
in these cases: please consult: http://www.elsevier.com/permissions.
Each Submission should contain separate documents as follows:
i. COVER LETTER. The cover letter should include: 1) title of the manu-
script; 2) name of the document ﬁ le(s) containing the manuscript and the 
software (and version) used; 3) name and all contact information for the 
corresponding author and a statement as to whether the data, models, 
or methodology used in the research are proprietary; 4) names of all 
sponsors of the research and a statement of all direct or indirect ﬁ nancial 
relationships the authors have with the sponsors; and 5) if applicable, a 
statement that the publication of study results was not contingent on the 
sponsor’s approval or censorship of the manuscript.
For a sample cover letter, see:
http://www.ispor.org/publications/VIHRI/SampleCoverLetter.doc.
ii. TITLE PAGE. The title page should contain the following: 1) title; 2) 
full names (ﬁ rst and surname) of all authors including academic degrees 
and afﬁ liation(s); 3) name, mailing and email addresses, telephone and fax 
numbers of corresponding author (with whom all correspondence will take 
place unless other arrangements are made); 4) all sources of ﬁ nancial or 
other support for the manuscript (if no funding was received, this should be 
noted on the title page); 5) at least four key words for indexing purposes; 
and 6) a running title of not more than 45 characters including spaces.
For a sample title page, see:
http://www.ispor.org/publications/VIHRI/SampleTitlePg.doc.
iii. MANUSCRIPTS. Manuscripts must be typed in either Microsoft 
Word (Version 5.0 or later) or WordPerfect (version 5.1 or later). Manu-
scripts should be in 8.5x11-inch page format, double-spaced with 1-inch 
margins on all sides and size 10 font (Arial or Times New Roman fonts 
are preferred). Minimal formatting should be used, i.e., no justiﬁ ca-
tion, italics, bold, indenting, etc. There should be no hard returns at 
the end of lines. Double-spacing after each element is requested (e.g., 
headings, titles, paragraphs, legends). The ‘Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals’ should be consulted for 
speciﬁ c style issues not addressed here (www.acponline.org, Ann Intern 
Med 1997;126:36-47). The word count should be less than 4500.
a. ABSTRACT. An abstract of 250 words or less is required,  summarizing 
the work reported in the manuscript. Original research manuscripts should 
use a structured format for the abstract, i.e., Objectives, Methods, Re-
sults, and Conclusions. A non-English research manuscript requires an 
abstract in English as well as in the language of the manuscript.
b. TEXT. The body of the manuscript should be divided into sec-
tions that facilitate reading and comprehension of the material. This 
should normally include sections with the major headings: Introduc-
tion, Methods, Results, Conclusions, Acknowledgments (if needed), 
and References. There should be no footnotes. Figures (inclusive 
of ﬁ gure legends) and Tables must be submitted each as separate 
documents.
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c. REFERENCES. References should be listed in a separate section 
and numbered consecutively with Arabic numerals in the order in which 
they are cited in the text. Citing unpublished or non-peer-reviewed work 
such as abstracts and presented papers is discouraged. Personal 
communications may be indicated in the text as long as written ack-
nowledgment from the authors of the communications accompanies 
the manuscript. Reference style should follow that of Index Medicus. 
Spell out single-word journals and abbreviate all others according to 
the style of Index Medicus. If there are more than four authors, use only 
the names of the ﬁ rst three, followed by et al. 
The three most common types of references are illustrated 
below for example.
Journal article: Surname and initials of author(s), title of article, 
name of journal, year, volume number, ﬁ rst and last page.
Arocho R, McMillan CA. Discriminant and criterion evaluation of the 
U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American 
population with benign hyperplasia. Med Care 1998;36:766–72.
Book: Surname and initials of author(s)/editor(s), title and subtitle, 
volume, edition (other than ﬁ rst), city, publisher, year.
Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill,
1984.
Chapter in Book: Surname and initials of author(s), title of chapter,
author(s)/editor(s) of book, title of book, volume, edition (other than
ﬁ rst), city, publisher, year.
Luce BR, Manning WG, Siegel JE, et al. Estimating costs in  cost-
effectiveness analysis. In: Gold MR, Siegel JE, Russell LB,  et al., 
eds., Cost-effectiveness in Health and Medicine. New York: Oxford 
University Press, 1996.
Website: Title of article on web. www.document. Available from: 
http://www... [Accessed Month day, year].
International Society for Pharmacoeconomics and Outcomes Re-
search (ISPOR) Good Outcomes Research Practices Index. Avail-
able from: http://www.ispor.org/workpaper/practices_index-.asp. 
[Acessed January 1, 2011].
For a sample manuscript, see:
http://www.ispor.org/publications/VIHRI/SampleManuscript.pdf. 
iv. TABLES. Tables should be clearly labeled, neatly typed, and easy 
to understand without reference to the text. Each should be double
spaced and presented on a separate page. Statistical estimates 
should indicate parameter estimates and, as appropriate, t ratios or 
standard error, statistical signiﬁ cance, sample size, and other relevant 
information. All abbreviations must be explained below each table. 
Each table should be numbered and have a self-explanatory title.
For a sample table, see:
http://www.ispor.org/publications/VIHRI/SampleTbls.doc.
v. FIGURES. Figures should each be submitted as a separate image 
ﬁ le, not embedded in the manuscript document or in a slide presentation. 
Cite ﬁ gures consecutively, as they appear in the text, with Arabic num-
bers (Figure 1, Figure 2, Figure 3A, etc.). If, together with your accepted 
article, you submit usable color ﬁ gures then the Journal will ensure, at 
no additional charge, that these ﬁ gures will appear in color on the Web 
(e.g., ScienceDirect and other sites) regardless of whether or not these 
illustrations are reproduced in color in the printed version. There will be a 
charge for color reproduction in print; you will receive information regard-
ing the costs from Elsevier after receipt of your accepted article. Please 
indicate your preference for color in print or on the Web only. Each ﬁ gure 
must be assigned a brief title (as few words as possible, and reserving ab-
breviations for the legend) as well as a legend. The corresponding legend 
should be typed double-spaced on a separate page. All symbols, arrows, 
and abbreviations must be explained in the legend. Please submit ﬁ les 
with a resolution of at least 300 DPI. Line artwork should contain a resolu-
tion of least 1000 DPI. Elsevier recommends submitting ﬁ gures in the 
following formats: TIFF, JPG, EPS, and PDF. Please be sure to delete any 
identifying patient information such as name, social security number, etc. 
Photographs in which a person’s face is recognizable must be accompa-
nied by a letter of release from that person explicitly granting permission 
for publication in the Journal. For any previously published material, writ-
ten permission for both print and electronic reprint rights must be ob-
tained from the copyright holder. For further explanation and examples of 
artwork preparation, see Elsevier’s Author Artwork Instructions at www.
elsevier.com/artwork.
For a sample ﬁ gure, see:
http://www.ispor.org/publications/VIHRI/SampleFigure.doc.
vi. SUPPLEMENTARY MATERIAL OR SUPPLEMENTAL DATA. You 
may submit appendixes that describe either methods or results in more 
detail if these are needed for clarity of understanding by either peer 
reviewers or readers. If appropriate, materials suitable for Web publica-
tion but not print publication (eg, audio or video ﬁ les, see below) can 
also be submitted. If you do so, indicate the particular reasons for the 
appendix and whether you are submitting it for possible Web publication 
or simply for peer review purposes. Value in Health Regional Issues ac-
cepts audio and video ﬁ les as ancillaries to the main article. Audio ﬁ les 
should be in .mp3 format; the recommended upper limit for the size of 
a single ﬁ le is 10 Mb. Video ﬁ les should be submitted in .mpg or .mp4 
format, the recommended upper limit for the size of a single ﬁ le is 10 
Mb. Any alternative format supplied may be subject to conversion (if 
technically possible) prior to online publication.
vii. SURVEY INSTRUMENT. For papers analyzing preferences, Value 
in Health Regional Issues requires the submission of a copy of the sur-
vey instrument used to generate the preference data. This is to help 
in the review process and the survey instrument need not appear in a 
ﬁ nal publication. If the authors wish the questionnaire to be published 
with the paper, it should be submitted as part of the paper. If they do 
not wish it to be published, it should be submitted as Supporting Infor-
mation and then will be sent to the reviewers as a reviewer’s appendix.
VII. DATA, MODELS, AND METHODOLOGY
All authors must agree to make their data available at the Editor’s 
 request for examination and re-analysis by referees or other persons 
designated by the Editor. All models and methodologies must be pre-
sented in  sufﬁ cient detail to be fully comprehensible to readers.
VIII. AUTHOR ANONYMITY
It is the policy of Value in Health Regional Issues that peer review of 
submitted manuscripts is double blinded, i.e., the reviewers do not know
the names of the authors of manuscripts and the authors do not know 
the names of the reviewers. Blinded reviews are common practice at 
many important scientiﬁ c and medical journals.
IX. THE REVIEW PROCESS
All manuscripts deemed appropriate for Value in Health Regional Issues after 
initial screening will be reviewed by at least two peer reviewers. The objective 
of the journal is to complete peer review and reach editorial decision within 
ten to twelve weeks of submission, at which time the corresponding author 
will receive written notiﬁ cation, including anonymous reviewer commentary.
X. AUTHOR TRACKING SERVICES
Authors may track accepted manuscripts (English only) at:
http://www.elsevier.com/trackarticle and set up e-mail alerts to inform 
them when an article’s status has changed. Contact details for questions 
arising after acceptance of an manuscript, especially those relating to 
proofs, will be provided by the publisher. For manuscripts not submitted 
in English, authors may query the Value in Health Regional Issues  Editorial 
 ofﬁ ce at: vihriasia@ispor.org, vihrila@ispor.org, or vihriceewaa@ispor.org.r.
XI. PROOFS
Proofs are to be sent electronically to Authors to review for printer’s 
errors. Substantive changes or additions to the edited manuscript 
cannot be allowed at this stage. Corrected proofs should be returned 
to the publisher within 2 days of receipt.
XII. OFFPRINTS
The corresponding author, at no cost, will be provided with a PDF ﬁ le of
the article via e-mail. For an extra charge, paper offprints can be ordered
via the offprint order form which is sent once the manuscript is accepted
for publication. The PDF ﬁ le is a watermarked version of the published
article and includes a cover sheet with the journal cover image and a
disclaimer outlining the terms and conditions of use.
